An independent informational overview of MEDVi's compounded tirzepatide telehealth program, including regulatory ...

But new research suggests that people on GLP-1s should focus on more than just protein. The scientific review, which was published in Obesity Reviews, highlights how people who take newer weight loss ...

Researchers report that intermittent fasting is no more effective for weight loss than other dietary routines. Experts say ...

Intermittent fasting has become a buzzword in nutrition circles, with many people looking to it as a way to lose weight or improve their health. But new research from the Cochrane Collaboration shows ...

By Dr. Priyom Bose, Ph.D. An examination of user reviews finds that people continue off-label Ozempic when it delivers results, even if side effects persist. Study: Patient Perceptions of Ozempic ...

An informational overview of Ivím Health's compounded semaglutide and tirzepatide telehealth program, including GLP-1 ID cost breakdown, weekly provider check-in structure, clinical claims analysis, a ...

The study found that the perceived effectiveness of Ozempic for weight loss is the primary driver of patient satisfaction and intent to continue treatment, even when experiencing side effects.

For those who enjoy structured eating, intermittent fasting can remain a viable option. For others, regular meals and mindful ...

A new study shows that people are likely to continue taking GLP-1 drugs like Ozempic, which is commonly prescribed off-label for weight loss, despite side effects like nausea, diarrhea, and abdominal ...

Research finds time-restricted eating isn't all it's cracked up to be.

Intermittent fasting has become one of the most talked-about weight loss trends in recent years, promising dramatic results with simple changes to when you eat. But a major Cochrane review suggests ...